清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

CD47 but Not Calreticulin Is over Expressed in Patients with Myeloproliferative Neoplasms

钙网蛋白 CD47型 骨髓纤维化 原发性血小板增多症 真性红细胞增多症 生物 髓样 外周血单个核细胞 免疫学 分子生物学 抗体 骨髓 内质网 细胞生物学 生物化学 体外
作者
Kristian Boasman,Matthew J. Simmonds,Ciro R. Rinaldi
出处
期刊:Blood [Elsevier BV]
卷期号:132 (Supplement 1): 5492-5492 被引量:1
标识
DOI:10.1182/blood-2018-99-118266
摘要

Abstract Myeloproliferative neoplasms (MPN) are chronic myeloid cancers characterized by the overproduction of mature blood cells, and the tendency to evolve into acute leukaemia. In solid tumours, calreticulin (CALR) overexpression on the cell surface, produces a pro-phagocytic signal and is counteracted by concomitant expression of anti- phagocytic CD47, reflecting an apoptosis vs survival mechanism. In this study, we investigated the expression of CALR and CD47 in patients with MPN and potential changes induced by treatment. CALR and CD47 gene and protein expression were measured by Real Time PCR and western blotting, in K562 and in mononuclear cells obtained by FICOLL separation, from peripheral blood of 13 MPN patients [4 Polycythaemia Vera, 8 Essential Thrombocythemia, and 1 myelofibrosis; 7 treated (IFN or Hydroxyurea) and 6 untreated] and compared with 4 healthy controls. Cells were also fractionised into 4 compartments: membrane, cytoplasm, cytosol and nucleus and protein fractions analysed. We found a significant increase in CD47 protein expression into the membrane of MPN patients comparing with controls (91.9 % vs 19.7%). Interestingly in treated MPN the CD47 expression increases even further in comparison with untreated (92.6% vs 91.9%). No significant differences were found in total CALR expression comparing with controls (3.23, vs 2.95-fold), however in treated patients we observed a reduction in the expression in the membrane comparing with untreated (26.4 % vs 39.5 %) and an increase into cytoplasm (69.4 % vs 54.6 %). These findings suggest CD47 exposure as a mechanism of defence in MPN cells during treatment. To better understand the potential effects of therapy on CALR and CD47 expression, we incubated K562 with 0.05μM/ml of Ruxolitinib (RUXO), re-dosed at 24 hours and harvested at 48 hours. RUXO induced CALR internalization, reducing its expression into the membrane (RUXO 8.2% vs Untreated: 13.3%), but increasing its expression in cytosol (RUXO 51% vs Untreated 48.4%) and in the cytoplasm (RUXO 13.5% vs Untreated 2.9%). In contrast, CD47 expression remains relatively unmodified, with only slight increases on the membrane (RUXO 43.1% vs Untreated 40.4%) and in the cytoplasm (RUXO 34.5% vs UT 32.5%). In this study we demonstrated that CD47 but not CALR, is overexpressed on the membrane of patients with MPN. This opposes previous studies in solid tumours, which show significant increases of both CALR and CD47. This suggests a role for CD47 as a strong anti-phagocytic signal responsible for immune survival in MPN. We have also shown a potential mechanism adopted by MPN cells in response to therapy, with the internalization of CALR and the enhanced membrane expression of CD47 which remains strongly expressed on cell surface. The addition of Anti-CD47 compounds in combination with conventional therapies might represent a future therapeutically strategy to counteract MPN cells immune-escape mechanism. Disclosures No relevant conflicts of interest to declare.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
慕青的应助被时之王者采纳,获得10
7秒前
kbcbwb2002完成签到,获得积分0
7秒前
蛋卷完成签到 ,获得积分0
9秒前
香蕉觅云的应助被猪敏爱椰枣采纳,获得10
10秒前
111完成签到 ,获得积分10
13秒前
雪山飞龙完成签到,获得积分10
19秒前
优雅的傲柏完成签到,获得积分10
31秒前
1分钟前
英姑的应助被Anywhere采纳,获得10
1分钟前
1分钟前
amiee发布了新的文献求助10
1分钟前
1分钟前
oleskarabach发布了新的文献求助30
1分钟前
笑傲完成签到,获得积分10
1分钟前
蓝意完成签到,获得积分0
1分钟前
时尚靖琪完成签到,获得积分10
1分钟前
顾矜的应助被科研通管家采纳,获得10
1分钟前
Aman完成签到,获得积分10
1分钟前
2分钟前
Anywhere发布了新的文献求助10
2分钟前
多情敏完成签到,获得积分10
2分钟前
crazy完成签到 ,获得积分10
2分钟前
dnpl完成签到,获得积分10
2分钟前
欢呼亦绿完成签到,获得积分10
2分钟前
张秀伟完成签到,获得积分10
2分钟前
Khan完成签到,获得积分10
2分钟前
Anywhere完成签到,获得积分10
2分钟前
Akim的应助被Fighter采纳,获得10
2分钟前
3分钟前
整齐念薇完成签到,获得积分10
3分钟前
Fighter发布了新的文献求助10
3分钟前
文静楷瑞完成签到,获得积分10
3分钟前
3分钟前
3分钟前
lyb1853完成签到 ,获得积分10
3分钟前
大模型的应助被Fighter采纳,获得10
4分钟前
迷路的穆完成签到,获得积分10
4分钟前
4分钟前
Fighter发布了新的文献求助10
4分钟前
沉默的黎昕完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190190
求助须知:如何正确求助?哪些是违规求助? 9577298
关于积分的说明 21852333
捐赠科研通 7788645
什么是DOI,文献DOI怎么找? 3436310
关于科研通互助平台的介绍 2560076
邀请新用户注册赠送积分活动 2482902